Skip to content

RDN-HT

Study of Renal Sympathetic Denervation with Radiofrequency Ablation Catheter for Resitant Essential Hypertension - RDN-HT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042180047
Enrollment
6
Registered
2019-02-14
Start date
2013-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistant hypertension

Interventions

Assessing safety and effectivess of renal sympathetic denervation in Japanese patients by the method of muscle sympathetic nerve activity

Sponsors

Takamura Masayuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients whose systolic pressure is beyond 160mmHg in spite of taking more than 3 kinds of antihypertensive drug(patients whose systolic pressure is beyond 150mmHg, if he is a diabetic)

Exclusion criteria

Exclusion criteria: 1)Anatomical anomaly of renal artery inappropriate for the operation 2)Estimated glomerular filtration rate is less than 45mL/min 3)History of myocardial infarction, angina pectoris, or cerebrovascular accident within 6 month 4)Type1 diabetes mellitus 5)Secondary Hypertension

Design outcomes

Primary

MeasureTime frame
1)Safety during perioperative period and chronic phase after the operation(evaluated with eGFR and imaging study) 2)Onset or progression of cardiovascular disease

Secondary

MeasureTime frame
1)Safety of the technique in the operation 2)Systolic blood pressure one year after the operation 3)Sympathetic nerve activity after the operartion(evaluated with muscle sympathetic nerve activity and blood hormone such as catecholamine)

Contacts

Public ContactHisayoshi Murai

Kanazawa University Hospital

sakurasoma1209@yahoo.co.jp+81-76-265-2238

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026